Evidence map›Paper›PMID 30621430›Full record

ArticleAIDS care2019

Prevalence of depressive symptoms and associated factors among adolescents living with HIV/AIDS in South Western Uganda.

Elizabeth Kemigisha, Brian Zanoni, Katharine Bruce, Ricardo Menjivar, Damazo Kadengye, Daniel Atwine, Godfrey Zari Rukundo

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 7 pooled it
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 7 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Elizabeth Kemigishaa Mbarara University of Science and Technology , Mbarara , Uganda.
Brian Zanonib Massachusetts General Hospital and Harvard Medical School , Boston , USA.
Katharine Brucea Mbarara University of Science and Technology , Mbarara , Uganda.
Ricardo Menjivarc University of Calgary , Calgary , Canada.
Damazo Kadengyed African Population and Health Research Center , Nairobi , Kenya.ORCID 0000-0001-7586-4928
Daniel Atwinea Mbarara University of Science and Technology , Mbarara , Uganda.
Godfrey Zari Rukundoe Department of Psychiatry, Mbarara University of Science and Technology , Mbarara , Uganda.
Mbarara University of Science and Technology · UGAfrican Population and Health Research Center · KEHarvard University · USUniversity of Calgary · CA

Funding

Mbarara University Research Training Initiative (MURTI)D43TW010128 · FIC · MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY · PI OBUA, CELESTINO · 2015 to 2019
$3.5M
FIC NIH HHS D43 TW010128
6 · The paper itself

Abstract

Adolescents living with HIV (ALHIV) are prone to depression, which can have detrimental effects including disease progression, poor treatment adherence and mortality. We aimed to determine the prevalence of depressive symptoms and their associated factors among ALHIV in Uganda. We conducted a cross-sectional survey among ALHIV (10-19 years) attending urban and rural clinics in Mbarara, Uganda between March and May 2017. Presence of depressive symptoms was assessed using the Centre for Epidemiological Studies' Depression scale. We interviewed 336 adolescents with a median age of 13 years, 62% of whom were female. A third (37%) had disclosed their HIV/AIDS status and 13% were sexually active. Overall, 154 (∼46%, [95% CI: 40.5-51.2]) had depressive symptoms. On bivariate analysis, the odds of having depressive symptoms were higher among adolescents who were ≥ 15 years, had disclosed HIV status, traveled >30 min for routine care and had risky sexual practices. On multiple variable analysis, only travel time to the clinic of >30 min was independently associated with depressive symptoms (AOR = 1.6 [95% CI: 1.02-2.7]). With the high prevalence of depressive symptoms among ALHIV in Uganda, screening and prompt treatment of depression should be incorporated within their routine care.

Indexed as

Antiretroviral Therapy, Highly ActiveAdolescentAnti-HIV AgentsChildCross-Sectional StudiesDepressionDisclosureFemaleHIV InfectionsHumansMaleMass ScreeningMedication AdherencePrevalenceSexual BehaviorUgandaAnti-HIV AgentsAdolescentsdepressive symptomsHIV/AIDSUganda

Identifiers

PMID30621430
PMCPMC6614012
OpenAlexW2910681525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.